Avion Wealth’s Fulgent Genetics FLGT Stock Holding History

Avion Wealth’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-56	Closed	-$1K	–	1364
2025 Q4	$1K	Hold	56	–	–	﹤0.01%	1023
2025 Q3	$1K	Hold	56	–	–	﹤0.01%	1010
2025 Q2	$1K	Buy	+56	New	+$1.09K	﹤0.01%	967

Other funds holding FLGT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Avion Wealth's FLGT Position: Q1 2026 in Review

Avion Wealth sold out of Fulgent Genetics (FLGT) in Q1 2026, closing a stake of 56 shares — an estimated $1K sold.

Avion Wealth first reported a position in FLGT in Q2 2025 and held it in 3 quarters. The position peaked at $1K in Q4 2025. 158 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

Avion Wealth reported no remaining Fulgent Genetics position as of Q1 2026 after selling out during the quarter.
Avion Wealth sold 56 Fulgent Genetics shares in Q1 2026, an estimated $1K.
Avion Wealth first reported a position in Fulgent Genetics in Q2 2025 and held it in 3 quarters.
Avion Wealth's Fulgent Genetics position peaked at $1K in Q4 2025.
158 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Avion Wealth's 13F filing for Q1 2026, filed 1 May 2026.